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192 ZONAL GENE EXPRESSION OF CHONDROCYTES IN
OSTEOARTHRITIC CARTILAGE
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N. Tanaka1, Y. Katsuragawa3, S. Yamamoto4, R. Suzuki1, S. Ikegawa2.
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and Joint Diseases, SNP Research Center, RIKEN, Tokyo, JAPAN,
3Department of Orthopaedic Surgery, International Medical Center of
Japan, Tokyo, JAPAN, 4Department of Orthopaedic Surgery, Tokyo
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Purpose: In osteoarthritis (OA), chondrocyte metabolism changes dra-
matically. Since chondrocyte metabolism is known to differ by depth
within articular cartilage, such metabolic change with OA could differ
among cartilage zones. In this study, we investigated the characteristics
of chondrocyte metabolism in respective cartilage zones of OA cartilage.
Methods: The study was performed under the approval of the ethical
committees of the institutes. OA cartilage was obtained from macroscop-
ically intact areas of 4 knee joints with end-stage disease. The cartilage
was divided into three cartilage zones (superﬁcial, middle and deep
zones) and gene expression proﬁles were determined in the respective
zones by a custom-designed microarray that focused on chondrocyte-
related genes. For genes the expression of which was signiﬁcantly dif-
ferent among the zones, the expression was compared between OA and
control cartilage in respective zones by an analysis using laser capture
microdissection (LCM) and real-time PCR. For several genes, correlation
of expression among OA cartilage samples was investigated in speciﬁc
cartilage zones.
Results: Approximately 40% of the genes investigated were found to be
expressed at signiﬁcantly different levels across the zones. Among them,
the expression of 25 genes (12 genes for cartilage components, 8 bone-
related genes, and 5 metalloproteinase genes) was compared between
OA and control cartilage in respective zones by LCM and real-time PCR,
which conﬁrmed the validity of the microarray analysis.
The expression of 12 cartilage component genes was all enhanced in
OA cartilage compared with that in the control. For these, the level of
enhancement was considerably different among the genes (2- to 220-
fold), suggesting that the balance of their synthesis might be considerably
disturbed in OA cartilage. In contrast, for all 12 genes, the difference
of expression levels among the three zones was very similar between
the OA and control cartilage, indicating that for each gene, the increase
of expression in OA cartilage occurred at a similar level throughout the
zones.
The expression of 8 bone-related genes was most enhanced in either
the superﬁcial (COL1A2, POSTN, TNA) or deep zone (COL10A1, IBSP,
SPARC, SPP1, WNT5B) within OA cartilage. Interestingly, the former
three genes are known to be expressed by osteoblasts, while two of
the latter are characteristically expressed by hypertrophic chondrocytes.
Since the expression of those genes was mutually correlated in the super-
ﬁcial and deep zones, respectively, their expression in OA cartilage was
assumed to be induced by the phenotypic change of the chondrocytes at
those zones.
The expression of 5 proteinase genes (MMP2, MMP3, MMP11, MMP13,
ADAMTS5) was all most enhanced in the superﬁcial zone within OA
cartilage. In that zone, their expression was mutually correlated, which
might suggest the presence of a common regulatory mechanism(s) for
their expression. Among the ﬁve genes, the expression of MMP11 and
MMP13 was most enhanced in OA cartilage (up to 40-fold increase),
implying that those proteinases could be deeply involved in the pathology
of OA.
Conclusions: In OA cartilage, the metabolic activity of chondrocytes dif-
fered considerably among zones. Characteristic changes were observed
in superﬁcial and deep zones.
193 MOLECULAR CONTROL OF ARCTICULAR CARTILAGE
DEGENERATION BY TRANSFORMING GROWTH FACTOR
ALPHA
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Purpose: Articular cartilage degeneration is a hallmark of osteoarthri-
tis (OA). We previously identiﬁed increased expression of transforming
growth factor alpha (TGFa) and chemokine (C-C motif) ligand 2 (CCL2)
in articular cartilage from a rat model of OA. We subsequently reported
that TGFa signaling modiﬁed chondrocyte cytoskeletal organization, in-
creased catabolic and decreased anabolic gene expression and sup-
pressed Sox9. Due to other roles in chondrocytes, we hypothesized that
the effects of TGFa on chondrocytes are mediated by Rho/ROCK and
MEK/ERK signaling pathways.
Methods: Primary cultures of chondrocytes and articular osteochondral
explants were treated with pharmacological inhibitors of MEK1/2 (U0126),
ROCK (Y27632), Rho (C3), p38 MAPK (SB202190) and PI3K (LY294002)
to elucidate pathway involvement.
Results: Using G-LISA we determined that stimulation of primary
chondrocytes with TGFa activates RhoA. Reciprocally, inhibition of
RhoA/ROCK but not other signaling pathways prevents modiﬁcation of the
actin cytoskeleton in response to TGFa. Inhibition of MEK/ERK signaling
rescued suppression of anabolic gene expression by TGFa including
SOX9 mRNA and protein levels. Inhibition of MEK/ERK, Rho/ROCK,
p38 MAPK and PI3K signaling pathways differentially controlled the
induction of MMP13 and TNFa gene expression. TGFa also induced
expression of CCL2 speciﬁcally through MEK/ERK activation. In turn,
CCL2 treatment induced the expression of MMP3 and TNFa. Finally,
we assessed cartilage degradation by immunohistochemical detection
of type II collagen cleavage fragments generated by MMPs. Blockade of
RhoA/ROCK and MEK/ERK signaling pathways reduced the generation
of type II collagen cleavage fragments in response to TGFa stimulation.
Conclusions: In conclusion, Rho/ROCK signaling mediates TGFa-
induced changes in chondrocyte morphology, while MEK/ERK signaling
mediates the suppression of Sox9 and its target genes, and CCL2
expression. CCL2, in turn, induces the expression of MMP3 and TNFa,
two potent catabolic factors known to be involved in OA. These pathways
may represent strategic targets for interventional approaches to treating
cartilage degeneration in osteoarthritis.
194 TRANSFORMING GROWTH FACTOR BETA 1
MEDIATED COLLAGEN BIOSYNTHESIS IN ARTICULAR
CHONDROCYTES IS DEPENDENT ON AN INTACT
MICROTUBULAR NETWORK
E.J. Blain, S.J. Gilbert, V.C. Duance. Cardiff University, Cardiff, UNITED
KINGDOM
Purpose: One of the major cytoskeletal architectures in chondrocytes is
the tubulin microtubules. Tubulin is essential for many fundamental cellu-
lar processes including mitosis and protein secretion. In chondrocytes, an
intact tubulin network has previously been shown to be required for secre-
tion of collagen and sulphated glycosaminoglycans (sGAG). Interestingly,
the spatial organisation of these networks has been observed to be
disrupted in human osteoarthritic chondrocytes or absent in a rat model
of osteoarthrosis. Therefore the aim of this study was to characterise the
effect of tubulin microtubule disassembly on articular chondrocyte matrix
synthesis and elucidate the mechanism(s) involved in this differential
regulation.
Methods: Chondrocytes from 7-day-old bovine articular cartilage were
plated at 1×106cells/well of a 24-well plate. Tubulin microtubules were
disrupted with 1mM colchicine over a 1, 3 or 7 day period, and dis-
assembly conﬁrmed by confocal microscopy. The effect of microtubule
disruption on de novo collagen and sGAG synthesis was measured by
incubating chondrocytes with 1 mM colchicine for 7 days in the pres-
ence of 20 mCi/ml [3H]-proline and 10 mCi/ml [35S]-sulphate; untreated
cultures served as controls. Unincorporated label was removed and
counts performed. Expression levels of b-tubulin and type II collagen
mRNA and protein were assessed by quantitative PCR and Western
blotting respectively. Expression and activation of TGFb1 was assessed
using an ELISA. Chondrocytes were subsequently pretreated with 1mM
colchicine for an hour prior to the addition of 10 ng/ml TGFb1 for 1, 3
or 7 days, and both Western blotting and quantitative PCR performed
to determine expression levels of type II collagen, TGFb1 and TGFb1
receptor. Downstream signalling effects i.e. activation of the MAP kinases
was monitored in tubulin-disrupted chondrocytes, in the presence or
absence of TGFb1. Restoration of matrix production was assessed by
pre-treating chondrocytes with selective MAPK inhibitors prior to addition
of colchicine.
Results: Disruption of the chondrocyte tubulin networks with 1mM
colchicine not only affected spatial organisation but also signiﬁcantly
inhibited the expression of both b-tubulin mRNA and protein over the
7 day culture period. De novo collagen and sGAG synthesis were
inhibited by tubulin disruption (stabilisation of the networks with 1mM
taxol enhanced the chondrocytic phenotype). In the absence of intact
tubulin networks, there was a signiﬁcant reduction in TGFb1. TGFb1 is a
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potent inducer of type II collagen synthesis in chondrocytes, but we have
found that if the tubulin networks are disrupted, TGFb1-induced collagen
mRNA and protein synthesis is prevented. However, expression levels
of TGFb1 and TGFb1-receptor mRNA are signiﬁcantly elevated in these
cells. Our preliminary studies suggest the involvement of both the MAPK
family (enhanced phosphorylation of both p38 and ERK1/2) and SMAD
family members, but studies are ongoing to elucidate the mechanism(s)
involved.
Conclusions: We have shown that modulation of the cytoskeletal tubulin
elements dramatically affects chondrocyte biosynthesis. We are cur-
rently characterising the mechanism(s) involved in these matrix changes.
Clearly there is a strong link between the correct assembly/turnover of
the microtubule network and tissue homeostasis. These studies will aid
in elucidating the role of the chondrocyte cytoskeleton in signal trans-
duction and provide an insight into how abnormal distribution/amounts of
cytoskeletal proteins may contribute to pathologies such as osteoarthritis.
195 F-SPONDIN ENHANCES MINERALIZATION DURING
CHONDROCYTE TERMINAL DIFFERENTIATION AND
INHIBITS TIBIAL GROWTH EX VIVO
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Purpose: We have previously shown that F-spondin, a thrombospondin-
related extracellular matrix protein, is expressed in embryonic growth
plate cartilage and localizes to hypertrophic and mineralizing chondro-
cytes undergoing ossiﬁcation. In this study, we investigate the role of
F-spondin in endochondral ossiﬁcation by examining its effects on chon-
drocyte terminal differentiation and limb formation, ex vivo.
Methods: Tibial organ cultures: To assess the effect of F-spondin on tibial
growth, embryonic mouse tibia (day 15.5) were harvested and cultured
for 1 week in DMEM + 10% FBS supplemented with either recombinant
F-spondin (0.5mg/ml), a TSR-domain speciﬁc F-spondin antibody (R1),
or media only. Longitudinal length was measured daily, up to 1 week, and
limbs were stained for mineral and cartilage with alizarin red and alcian
blue respectively. In vitro chondrocyte differentiation: chondrocytes were
isolated from the cephalic portion of 14-day old embryonic chick sterna
and transfected with F-spondin cDNA using GenePorter transfection
reagent (Genlantis, San Diego, CA). The following day, cultures were
treated with 100 nM retinoic acid (RA) to induce terminal differentiation.
Differentiation was assessed by measuring alkaline phosphatase enzyme
activity (AP) after 5 days, and evaluating mineral deposition by Von Kossa
staining after 7 days.
Results: F-spondin treatment decreased longitudinal growth of tibia in or-
gan culture by ~8% compared to untreated controls. Similarly, F-spondin
inhibition, by antibody treatment, increased limb length by approximately
the same magnitude. Upon histological examination, all treatment groups
contained a central mineralized area identiﬁed by alizarin red staining,
however, within the F-spondin treated group this region extended toward
the epiphyseal regions, but remained cartilaginous (alcian blue positive)
within untreated controls. Based on these observations, we investigated
whether F-spondin regulates chondrocyte mineralization using an in vitro
model for chondrocyte terminal differentiation. Exposure of chick chon-
drocytes to RA (100 nM) induced AP activity and mineral deposition,
indicated by Von Kossa staining. Overexpression of F-spondin cDNA
augmented both RA-mediated induction of AP activity (4-fold; p< 0.05)
and mineral deposition compared to mock transfected cells. To determine
whether avb3 integrin is required for this promineralizing effect, we
measured AP activity in the presence of LM609, a blocking antibody
to avb3. In the presence of RA only, LM609 did not affect AP activity,
however F-spondin-mediated AP induction was decreased 40% (p< 0.05)
compared to control, indicating that this effect is mediated, in part, via
interaction with avb3 integrin.
Conclusions: F-spondin decreases tibial growth in organ culture and
enhances chondrocyte mineralization in vitro. We propose that, via
interaction with avb3 integrin, F-spondin regulates limb formation by
controlling chondrocyte mineralization within the growth plate.
196 DISRUPTION OF LIPID HOMEOSTASIS IN
CARTILAGE-SPECIFIC SITE-1 PROTEASE KNOCKOUT MICE
RESULTS IN ENDOPLASMIC RETICULUM STRESS AND
POOR CARTILAGE PRODUCTION
D. Patra, J. Bryan, X. Xing, L.J. Sandell. Washington University School
of Medicine, St. Louis, MO, USA
Purpose: Site-1 protease (S1P) plays an essential role in the regulated
processing of ER membrane-bound transcription factors SREBPs and
ATF6 to their free and active form. SREBPs are involved in cholesterol and
fatty acid homeostasis; ATF6 is involved in endoplasmic reticulum stress
signaling (ERSS). Cartilage-speciﬁc knockout of S1P in mice (S1Pcko)
results in poor cartilage with a drastic decrease of collagen type IIB (Col
IIB) in the matrix and consequent complete lack of endochondral bone for-
mation. Most of the Col IIB appears trapped inside the cell. Ultrastructural
analysis of the cartilage shows engorged and fragmented endoplasmic
reticulum (ER) characteristic of ER stress. The ER is important for protein
synthesis and folding. Maintenance of ER integrity and a cell’s ability to
respond to ER stress is important to its function. S1Pcko mice would be
expected to lack both active SREBPs and ATF6. The goal of this study is
to identify and analyze pathways related to ER stress and ERSS affected
by the absence of S1P in S1Pcko cartilage.
Methods: RNA was extracted from the cartilage of E16.5 S1Pcko and
wild type littermates followed by genome-wide expression proﬁling using
Illumina MouseWG-6 v2 Expression BeadChip which proﬁles 46,643
mouse transcripts. Statistically signiﬁcant differential gene expression
was analyzed using Partek Genomics Suite’s 2-way ANOVA analysis.
Ingenuity Pathway Analysis v6 was used to identify signiﬁcantly affected
biological pathways. The RNA was also used for RT-PCR conﬁrmation
of expression proﬁling. In situ hybridization and RT-PCR analysis was
performed for analyzing genes in ER stress signaling pathways.
Results: In adult mammalian cells, ER stress signaling involves coordi-
nating responses from three ER proteins, PERK, IRE1 and ATF6. PERK is
involved in the attenuation of translation which results in increased ATF4
activity in response to ER stress. Expression proﬁling shows that ATF4
is signiﬁcantly up-regulated in S1Pcko cartilage compared to wild type
indicating that the PERK pathway is intact. RT-PCR analysis of XBP1
splicing governed by IRE1 in response to ER stress is also normal in
S1Pcko cartilage. In addition, genome-wide expression proﬁling suggests
that ATF6 may be poorly expressed in embryonic mouse cartilage and
thus it may not play a role. These data suggest that in general ERSS
may function normally in S1Pcko cartilage. Expression proﬁling followed
by Ingenuity Pathway Analysis of statistically signiﬁcant differentially ex-
pressed genes demonstrate that pathways leading to lipid and cholesterol
synthesis which play a role in ER membrane integrity is down-regulated
in S1Pcko cartilage. This was further conﬁrmed for several genes by RT-
PCR analysis.
Conclusions: The ER is the site of fatty acid and cholesterol synthesis
and correct composition of fatty acids and sterols would be essential to
maintain ER membrane integrity and therefore its function. A chondrocyte
is a secretory cell and the ER its essential secretory apparatus and
therefore maintaining ER lipid composition would be critical. In S1Pcko
mice, ER stress signaling appears to function normally. However, the
down-regulation of fatty acid and cholesterol synthesis in S1Pcko mice
may lead to poor ER membrane integrity and therefore ER fragmentation
and engorgement presumably due to an inability to secrete Col IIB and
therefore ER stress. These data suggest that in embryonic cartilage S1P
is primarily involved in maintaining ER membrane integrity by upholding
lipid homeostasis and preventing ER stress. This study provides a link to
the importance of lipids in cartilage and bone development and should
be useful in cartilage diseases and tissue engineering.
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Purpose: Proinﬂammatory mediators, mechanical load as well as hypoxia
are known to be involved in the pathogenesis of osteoarthritis. All these
factors are important in the regulation of articular chondrocyte behaviour
during cartilage homeostasis and osteoarthritis. The aim of this work was
